WHO: New Technical Report (TRS 1060) Published
The WHO has released a series of new and updated guidelines related to pharmaceutical manufacturing, testing, and development, published as part of Technical Report Series No. 1060 (TRS 1060). Annexes 2 through 9 address a range of topics, including nitrosamine control, GMP for excipients, bioanalytical methods and blood establishments.
The following appendices are relevant to GMP:
- Annex 2: WHO good practice considerations for the prevention and control of nitrosamines in pharmaceutical products – new
- Annex 3: WHO good manufacturing practices for excipients used in pharmaceutical products – new: Appendix 1 and 2 (risk management and list of examples of high-risk excipients and contaminants)
- Annex 4: Good practices for blood establishments – updated
- Annex 6: Guideline on bioanalytical method validation and study sample analysis – new
Source:
WHO: WHO Expert Committee on Specifications for Pharmaceutical Preparations, 58th Report
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
